-+ 0.00%
-+ 0.00%
-+ 0.00%

PSYENCE BIOMEDICAL LTD - WILL OBTAIN EXCLUSIVE RIGHTS TO OPTIMI'S DRUG CANDIDATE FOR TREATMENT USE IN PALLIATIVE CARE CONTEXT

Reuters·12/10/2024 12:30:00

Please log in to view news